Search in:

Drug Design, Development and Therapy Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Sachio Fushida1 Department of Gastroenterological Surgery, Kanazawa University Hospital, KanazawaCorrespondence[email protected]

Jun Kinoshita1 Department of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa

Masahide Kaji2 Department of Surgery, Toyama Prefectural Central Hospital, Toyama

Katsunobu Oyama1 Department of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa

Yasuo Hirono3 First Department of Surgery, Fukui University Hospital, Fukui

Tomoya Tsukada2 Department of Surgery, Toyama Prefectural Central Hospital, Toyama

Takashi Fujimura4 Department of Surgery, Toyama City Hospital, Toyama, Japan

Tetsuo Ohta1 Department of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa

show all

Pages 2353-2358 | Published online: 25 Jul 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (22)

Lauren A. Abderhalden, Ping Wu, Mayur M. Amonkar, Brian M. Lang, Sukrut Shah, Fan Jin, Andrew M. Frederickson & Ali Mojebi. (2023) Clinical Outcomes for Previously Treated Patients with Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Literature Review and Meta-Analysis. Journal of Gastrointestinal Cancer 54:4, pages 1031-1045.
Crossref

Xiao-fan Luo, Ye-hao Luo, Xin-yi Zhao, Xue-ting Lin, Wen-ling Li, Jie Jie, Di Wu, Gang Fang, Yu-zhou Pang & An Huang. (2023) Application and progress of palliative therapy in advanced gastric carcinomas. Frontiers in Oncology 13.
Crossref

Ayesha Safdar & Fatima Ismail. (2023) A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid. Saudi Pharmaceutical Journal 31:2, pages 265-278.
Crossref

Marina Leite, Raquel Seruca & Jorge M. Gonçalves. 2023. Hereditary Gastric and Breast Cancer Syndrome. Hereditary Gastric and Breast Cancer Syndrome 281 320 .

Diana Araújo, Eduarda Ribeiro, Irina Amorim & Nuno Vale. (2022) Repurposed Drugs in Gastric Cancer. Molecules 28:1, pages 319.
Crossref

Dhirendra Singh, Sumeet Gupta, Inderjeet Verma, Mohamed A. Morsy, Anroop B. Nair & Al-Shaimaa F. Ahmed. (2021) Hidden pharmacological activities of valproic acid: A new insight. Biomedicine & Pharmacotherapy 142, pages 112021.
Crossref

Daniel V. Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J. Klempner, Zev A. Wainberg, Manish A. Shah, Sun Young Rha, Atsushi Ohtsu, Astra M. Liepa, Holly Knoderer, Anindya Chatterjee & Eric Van Cutsem. (2021) Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma. The Oncologist 26:10, pages e1704-e1729.
Crossref

Xu Yang, Jing Liu, Qing Liang & Guangchun Sun. (2020) Valproic acid reverses sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in hepatocellular carcinoma. Fundamental & Clinical Pharmacology 35:4, pages 690-699.
Crossref

Ahmet Yardım, Sefa Kucukler, Selçuk Özdemir, Selim Çomaklı, Cuneyt Caglayan, Fatih Mehmet Kandemir & Hamit Çelik. (2021) Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats. Gene 769, pages 145239.
Crossref

Feng Li, Jing Zhang, Chao Ma, Ziqian Wang, Yinhua Li, Jimin Zhao & Kangdong Liu. (2020) Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma. Current Pharmacology Reports 6:6, pages 415-428.
Crossref

Yoko Tomita, Max Moldovan, Rachael Chang Lee, Amy HC Hsieh, Amanda Townsend & Timothy Price. (2020) Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma. Cochrane Database of Systematic Reviews 2020:11.
Crossref

Dimitrios Schizas, Aikaterini Mastoraki, Leon Naar, Diamantis I. Tsilimigras, Ioannis Katsaros, Vasiliki Fragkiadaki, Georgia-Sofia Karachaliou, Nikolaos Arkadopoulos, Theodore Liakakos & Dimitrios Moris. (2020) Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role. Current Medicinal Chemistry 27:36, pages 6099-6111.
Crossref

Zeki Serdar Ataizi, Kemal Ertilav & Mustafa Nazıroğlu. (2019) Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca2+ influx and inflammatory cytokine molecular pathways in the docetaxel-treated mice by melatonin and selenium treatments. Metabolic Brain Disease 34:4, pages 1077-1089.
Crossref

Xing Lyu, Min Hu, Jieting Peng, Xiangyu Zhang & Yan Y Sanders. (2019) HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis. Therapeutic Advances in Chronic Disease 10, pages 204062231986269.
Crossref

Yuri Ishiguro, Masaki Kobayashi, Masaya Ideno, Katsuya Narumi, Ayako Furugen & Ken Iseki. (2018) Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity. International Journal of Pharmaceutics 551:1-2, pages 97-102.
Crossref

Bing Peng, Chao Li, Peng Cai, Liuyang Yu, Bolin Zhao & Guiming Chen. (2018) Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancer. Molecular Medicine Reports.
Crossref

Valentina Fanotto, Mario Uccello, Irene Pecora, Lorenza Rimassa, Francesco Leone, Gerardo Rosati, Daniele Santini, Riccardo Giampieri, Samantha Di Donato, Gianluca Tomasello, Nicola Silvestris, Filippo Pietrantonio, Francesca Battaglin, Antonio Avallone, Mario Scartozzi, Eufemia Stefania Lutrino, Davide Melisi, Lorenzo Antonuzzo, Antonio Pellegrino, Laura Ferrari, Roberto Bordonaro, Caterina Vivaldi, Lorenzo Gerratana, Silvia Bozzarelli, Roberto Filippi, Domenico Bilancia, Marco Russano & Giuseppe Aprile. (2017) Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy. The Oncologist 22:12, pages 1463-1469.
Crossref

Ernestina Marianna De Francesco, Marcello Maggiolini, Herbert B. Tanowitz, Federica Sotgia & Michael P. Lisanti. (2017) Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy. Oncotarget 8:34, pages 56126-56142.
Crossref

Yu Zheng, Xu-Qing Zhu & Xiao-Gang Ren. (2017) Third-line chemotherapy in advanced gastric cancer. Medicine 96:24, pages e6884.
Crossref

Angela DautiBrigitte GerstlSerena ChongOrin ChisholmAntoinette Anazodo. (2017) Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients. Journal of Adolescent and Young Adult Oncology 6:2, pages 235-269.
Crossref

Bo Zhu, Lichun Sun, Wei Luo, Min Li, David H. Coy, Long Yu & Wenbo Yu. (2017) Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2. Oncotarget 8:14, pages 23289-23302.
Crossref

Yan Chen, Wandan Huang, Feiyu Chen, Guoping Hu, Fenglei Li, Jianhua Li & Aiguo Xuan. (2016) Pregnane X receptors regulate CYP2C8 and P‐glycoprotein to impact on the resistance of NSCLC cells to Taxol. Cancer Medicine 5:12, pages 3564-3571.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Articles from other publishers (22)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Citations (22)

Articles from other publishers (22)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date